Cns Pharmaceuticals Inc (NASDAQ:CNSP) currently has a daily average trading volume of 4.74M but it saw 3555732 shares traded in last market. With a market cap of 0.40M USD, the company’s current market price of $0.14 came rising about 1.81 while comparing to the previous closing price of $0.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $137.50 and as low as $0.13. In the recent trading on the day, stock has struck highest price mark of $0.1252 while lowest mark touched by it was $0.141.
Taking a look at 20-day trading activity of Cns Pharmaceuticals Inc (CNSP) gives us an average price of $0.5131, while its current price level is -99.90% below from 52-week high level whereas it is 8.50% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.5578 while that of 200 days or SMA-200 reads an average of $29.9701. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.17% during that period while stretching the period over a month that increases to 28.68%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.45 which implies that the stock is in oversold territory.
Over the week, CNSP’s stock price is moving -19.43% down while it is -87.18% when we observe its performance for the past one month. Year-to-date it is -99.78% down and over the past year, the stock is showing a downside performance of -99.84%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -2.1 beat the consensus estimate of -3.3 for the same. The company is expected to be releasing its next quarterly report on 2024-Aug-15, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Cns Pharmaceuticals Inc’s total number of outstanding shares is 2.87M. Company’s return on equity (ROE) at -1018.78%. Stock’s beta reads 1.14. Its return on asset (ROA) is -384.86% on average.
